Oral Branched-chain Amino Acid Supplementation for Cirrhotic Patients With Sarcopenia

PHASE3Enrolling by invitationINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

November 15, 2023

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
SarcopeniaCirrhosis of the Liver
Interventions
DRUG

Branched-chain amino acid

In the BCAA group, participants will receive oral BCAA for 24 weeks, with a daily dosage of approximately 13.68 g/day. Each sachet of BCAA will contain 6.84 g of BCAA (valine 1.82 g, leucine 3.29 g, isoleucine 1.72 g), total protein 17.08 g, carbohydrates 25.48 g, fat 5.66 g, providing 221.2 kcal of energy. Each sachet weighs 52 g and should be mixed with 150 ml of water. Participants will consume 2 sachets daily, one after breakfast and one after dinner.

DRUG

Placebo

In the placebo group, BCAA will be replaced with maltodextrin. Each sachet of the placebo will contain a total of 5.93 g of protein, 35.87 g of carbohydrates, 6.00 g of fat, providing 221.2 kcal of energy. Like the BCAA sachets, each placebo sachet will weigh 52 g and should be mixed with 150 ml of water. Participants in the placebo group will consume 2 sachets daily, one after breakfast and one after dinner.

Trial Locations (1)

10700

Division of Gastroenterology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand, Bangkok

All Listed Sponsors
lead

Mahidol University

OTHER